Hi there,

Please don’t turn away from this message. Democracy Now! is a free source of independent news for tens of millions of people around the world, but less than 1% of our global audience donates to support our critical journalism. Let’s pick up the percentage! Today, a generous contributor will DOUBLE your donation to Democracy Now!, which means if you give $10, we’ll get $20. Please don’t miss out on this opportunity to double your impact. Democracy Now! doesn't accept advertising income, corporate underwriting or government funding because nothing is more important to us than our editorial independence. We rely on you for support—and we’re counting on you right now. I hope you’ll give as much as you can today. Every dollar makes a difference. Thanks so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


Eli Lilly Lowers Price of Insulin After Intense Public Pressure

HeadlineMar 03, 2023

Eli Lilly has announced it is lowering the price of insulin by 70%, capping its out-of-pocket cost at $35, and offering its generic insulin at $25. The move follows years of organizing and pressure from activists, lawmakers, and people with diabetes. In response, Senator Bernie Sanders wrote to the drug companies Sanofi and Novo Nordisk demanding they follow suit. Sanders wrote, “Insulin is not a new drug. It was discovered 100 years ago by Canadian scientists who sold the patent rights of insulin for just $1 because they wanted to save lives, not make pharmaceutical executives extremely wealthy. And yet, as a result of unacceptable corporate greed, the price of insulin has gone up by over 1,000 percent since 1996 causing 1.3 million people with diabetes to ration insulin last year while your companies made billions of dollars in profits.”

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation